AU2003244181A1 - Phenoxypyridine derivative or salt thereof - Google Patents

Phenoxypyridine derivative or salt thereof

Info

Publication number
AU2003244181A1
AU2003244181A1 AU2003244181A AU2003244181A AU2003244181A1 AU 2003244181 A1 AU2003244181 A1 AU 2003244181A1 AU 2003244181 A AU2003244181 A AU 2003244181A AU 2003244181 A AU2003244181 A AU 2003244181A AU 2003244181 A1 AU2003244181 A1 AU 2003244181A1
Authority
AU
Australia
Prior art keywords
salt
phenoxypyridine derivative
phenoxypyridine
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003244181A
Inventor
Akio Kakefuda
Takahiro Kuramochi
Takashi Ogiyama
Toshio Okazaki
Ippei Sato
Takayuki Sato
Taku Taguchi
Issei Tsukamoto
Hiroyoshi Yamada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of AU2003244181A1 publication Critical patent/AU2003244181A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
AU2003244181A 2002-06-25 2003-06-24 Phenoxypyridine derivative or salt thereof Abandoned AU2003244181A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002-184408 2002-06-25
JP2002184408 2002-06-25
PCT/JP2003/007993 WO2004000813A1 (en) 2002-06-25 2003-06-24 Phenoxypyridine derivative or salt thereof

Publications (1)

Publication Number Publication Date
AU2003244181A1 true AU2003244181A1 (en) 2004-01-06

Family

ID=29996703

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003244181A Abandoned AU2003244181A1 (en) 2002-06-25 2003-06-24 Phenoxypyridine derivative or salt thereof

Country Status (3)

Country Link
JP (1) JPWO2004000813A1 (en)
AU (1) AU2003244181A1 (en)
WO (1) WO2004000813A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4795022B2 (en) 2003-09-30 2011-10-19 エーザイ・アール・アンド・ディー・マネジメント株式会社 Novel antifungal agent containing a heterocyclic compound
JP4874958B2 (en) 2005-03-30 2012-02-15 エーザイ・アール・アンド・ディー・マネジメント株式会社 Antifungal agents containing pyridine derivatives
TWI385169B (en) 2005-10-31 2013-02-11 Eisai R&D Man Co Ltd Heterocyclic substituted pyridine derivatives and antifungal agent containing same
EP2065377B1 (en) 2006-09-21 2011-11-23 Eisai R&D Management Co., Ltd. Pyridine derivative substituted by heteroaryl ring, and antifungal agent comprising the same
CN102702185A (en) 2007-04-27 2012-10-03 卫材R&D管理有限公司 Heterocycle-substituted pyridine derivative's salt or crystal thereof
US8513287B2 (en) 2007-12-27 2013-08-20 Eisai R&D Management Co., Ltd. Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same
US8188119B2 (en) 2008-10-24 2012-05-29 Eisai R&D Management Co., Ltd Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same
US8912224B2 (en) 2011-09-12 2014-12-16 Sanofi Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals
SI2567958T1 (en) 2011-09-12 2015-01-30 Sanofi Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals
CA2846347C (en) 2011-09-12 2019-05-21 Sanofi Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals
TWI633095B (en) 2013-03-08 2018-08-21 賽諾菲公司 Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticals

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU726239B2 (en) * 1997-03-27 2000-11-02 Taisho Pharmaceutical Co., Ltd. 2-phenoxyaniline derivatives
JPH1149752A (en) * 1997-08-05 1999-02-23 Taisho Pharmaceut Co Ltd Phenoxypyridine derivative
JP4162100B2 (en) * 1997-09-17 2008-10-08 大正製薬株式会社 Phenoxypyridine derivative

Also Published As

Publication number Publication date
JPWO2004000813A1 (en) 2005-10-20
WO2004000813A1 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
HUS1900052I1 (en) 2-acylaminothiazole derivative or salt thereof
ZA200500621B (en) 2-cyano-4-fluoropyrrolidine derivative or its salt
AU2003248259A1 (en) Novel azetidine derivative or salt thereof
EP1682493B8 (en) Amidoacetonitrile derivatives
AU2003274025A1 (en) Pyridine derivatives useful as herbicides
AU2003296586A1 (en) Pyridazinone derivatives as cdk2-inhibitors
AU2003211362A1 (en) N-hydroxycarboxamide derivative
AU2003255492A1 (en) Heterocyclic derivatives
AU2003275632A1 (en) N-oxide compounds
EP1606277B8 (en) Imidazol-4-yl-ethynyl-pyridine derivatives
AU2003227712A1 (en) Tetrahydroisoquinoline derivatives
AU2003301968A1 (en) 4-aminomethyl-1-aryl-cyclohexylamine derivatives
AUPS015902A0 (en) Hanger bar
AU2003244181A1 (en) Phenoxypyridine derivative or salt thereof
EP1706373B8 (en) Amidoacetonitrile derivatives
AU2003278369A1 (en) 3-cyano-quinoline derivatives
AU2003296564A1 (en) 4-hydroxymethyl-1-aryl-cyclohexylamine derivatives
AU2003222659A1 (en) 23-o-substituted 5-o-mycaminosyltylonide derivatives
AU2003234131A1 (en) 5-o-mycaminosyltylonide derivatives
AU2003269949A1 (en) Substituted 1,4-pyrazine derivatives
AU2003274551A1 (en) Quinoline derivatives
AU2003258598A1 (en) Substituted 1,2,3,4-tetrahydroquinoline derivatives
AU2003273398A1 (en) Aroyl-piperidine derivatives
AU2002249639A1 (en) Pyranocoumarin derivatives
AU2003238180A1 (en) 2-naphtamide derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase